ArticleInvestigational new drugs2016

A dose escalating phase I study of GLPG0187, a broad spectrum integrin receptor antagonist, in adult patients with progressive high-grade glioma and other advanced solid malignancies.

Geert A Cirkel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.